GleamWall
中文EN

BBNX Beta Bionics, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1674632 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY43.7%
TTM net income YoY-6.8%
TTM EPS YoY57.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin58.6%
Operating margin-72.7%
Net margin-65.3%
FCF margin-51.8%
EBITDA margin-70.6%

Returns

ROE-23.9%
ROA-21.5%
ROIC (approx.)-25.4%
Asset turnover0.33x

Leverage & solvency

Liabilities / assets9.5%
Debt / equity0.00x
Current ratio8.92x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.71x
Accruals ratio-6.1%
Payout ratio—
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$100.25M$65.12M$11.99M
Cost of revenue$44.71M$29.24M$5.69M
Gross profit$55.54M$35.89M$6.31M
R&D expense$34.79M$26.18M$17.94M
SG&A expense$31.02M$17.87M$12.22M
Operating income-$71.68M-$45.25M-$35.85M
Income tax$0$0—
Net income-$73.20M-$54.76M-$44.10M
EBITDA-$70.11M-$44.10M-$34.62M
EPS (basic)-1.81-8.60-8.31
EPS (diluted)-1.81-8.60-8.31
Weighted avg. shares (diluted)40.53M6.37M5.30M
Balance sheet
Cash & equivalents$31.58M$30.53M$26.67M
Short-term investments$187.55M$73.14M$70.18M
Receivables$17.12M$12.00M$4.45M
Inventory$21.72M$13.32M$1.25M
Current assets$267.90M$132.92M$103.62M
PP&E, net$8.60M$4.78M$2.48M
Total assets$328.74M$149.65M$110.04M
Current liabilities$30.92M$21.15M$10.61M
Total liabilities$41.13M$73.63M$51.43M
Shareholders' equity$287.61M-$245.36M-$203.10M
Shares outstanding44.36M6.67M—
Cash flow statement
Operating cash flow-$50.92M-$48.27M-$32.45M
Capital expenditure$5.30M$3.40M$402,000
Free cash flow-$56.22M-$51.67M-$32.85M
Investing cash flow-$162.81M-$3.48M-$69.69M
Financing cash flow$214.87M$55.62M$101.03M
Depreciation & amortization$1.57M$1.15M$1.23M
Stock-based compensation$16.38M$6.38M$5.66M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.